Skip to main content

Analysts’ Opinions Are Mixed on These Energy Stocks: Cenovus Energy (CVE) and North American Construction Group (NOA)

Tipranks - Tipranks - Sun Nov 16, 2025

Analysts have been eager to weigh in on the Energy sector with new ratings on Cenovus Energy (CVE – Research Report) and North American Construction Group (NOA – Research Report).

Meet Your ETF AI Analyst

Cenovus Energy (CVE)

Jefferies analyst Lloyd Byrne maintained a Buy rating on Cenovus Energy today and set a price target of C$30.00. The company’s shares closed last Friday at $18.13.

According to TipRanks.com, Byrne is a 5-star analyst with an average return of 17.0% and a 56.5% success rate. Byrne covers the NA sector, focusing on stocks such as Baker Hughes Company, Occidental Petroleum, and Antero Resources. ;'>

Currently, the analyst consensus on Cenovus Energy is a Strong Buy with an average price target of $20.98, a 18.3% upside from current levels. In a report issued on October 31, Raymond James also maintained a Buy rating on the stock with a C$32.00 price target.

See the top stocks recommended by analysts >>

North American Construction Group (NOA)

In a report released yesterday, Chris Thompson MBA from CIBC maintained a Hold rating on North American Construction Group, with a price target of C$22.00. The company’s shares closed last Friday at $13.90.

According to TipRanks.com, MBA is ranked #3057 out of 10123 analysts.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for North American Construction Group with a $16.82 average price target.

Read More on CVE:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).